Market Dynamics and Competitive Landscape of Inosine Pranobex By 2023 to 2028 The global inosine pranobex market is expected to reach US$ 234.5 million by 2028, growing at a CAGR of 2.2%. The growth of the market is attributed to the increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and influenza. Inosine pranobex is a drug that has been shown to be effective in the treatment of these diseases.
Inosine...
0 Shares
618 Views
0 Reviews